These findings clearly demonstrate that AAT not only inhibits DSS-mediated colonic inflammation, but also suppresses AOM-DSS-established colon tumor growth in part, if not only, through the increase of antitumor and anti-inflammatory IGFBP-3 levels in colon tissue. The gene discussed is IGFBP3; the disease is colonic neoplasm.